Amal K. Mukhopadhyay Director Trained as biochemist with a focus on endocrinology and biotechnology, a reputed scientist with long term experience in business development. Curriculum Vitae

The pharmaceutical and health care industry is focused on reducing the cost and time taken by the drug discovery value chain through close collaboration with biotechnological companies.

In India, pharmaceutical industry is on a high growth path being now an $8 billion industry. Also, in 2004-2005, the Indian biotech industry reached $1 billion mark in turnover and is expected to generate $5 billion by 2010, thus recording a growth of 30-40% annually.

With cost effective and skilled manpower in abundance, strong knowledge in chemistry and life sciences coupled with power in computing, India is proving to be an internationally accepted partner in manufacturing and exporting active pharmaceutical ingredients, drug intermediates, and biogenerics as well as in biotechnological R&D.

R&D, especially in biotechnology, can be carried out in India at a fraction of the equivalent costs in Europe or the US. Partnership between European and Indian Pharmaceutical companies can accelerate clinical research and reduce bottlenecks in clinical data management.

Indian healthcare and pharmaceutical market is on a rapid growth path, with unmet needs of an expanding middle class families with considerable purchasing power.

ELGA Biotech has strong roots both in India and Europe with wide ranging knowledge and expertise in business culture, business development, management, financing, R&D and marketing. Let ELGA Biotech serve you by taking care of all your needs in your plans of cross-border partnership for a profitable future.

Petra Stegemann, MA Business Development & Marketing Germanist and scientific librarian. Long term experience as Head of a Scientific Library. Since 2003 self-employed offering services for science and research. www.science-support.eu